Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Obes Surg. 2015 Jun;25(6):1024–1030. doi: 10.1007/s11695-014-1468-7

Table 2.

Postanesthesia care unit events that could delay recovery from anesthesia

Events of treatments Prolonged recoverya
P value
No (n=477)b Yes (n=304)c
Respiratory-specific events 6 (1.3) 29 (9.5) <0.001
Postoperative nausea and vomiting 92 (19.3) 106 (34.9) <0.001
Intravenous morphine equivalents, median (interquartile), mg 5.0 (0.0–10.5) 10.0 (3.0–15.0) <0.001
Antihypertensive medication administrationd 33 (6.9) 49 (16.1) <0.001
Vasopressor medication administratione 0 2 (0.7) 0.15
a

Values are presented as number and percentage of patients unless specified otherwise

b

Phase I postanesthesia recovery ≤90 min

c

Phase I postanesthesia recovery >90 min

d

Hydralazine was administered to 3 patients discharged in ≤90 min and to 13 patients discharged in >90 min. Labetalol was administered to 43 vs 29 patients and metoprolol to 2 vs 2 patients in the groups discharged in ≤90 vs >90 min, respectively

e

Phenylephrine boluses were administered to 2 patients